Basit öğe kaydını göster

dc.contributor.authorGenç, Deniz
dc.contributor.authorBulut, Osman
dc.contributor.authorGünaydın, Burcu
dc.contributor.authorGöksu, Mizgin
dc.contributor.authorDüzgün, Mert
dc.contributor.authorDere, Yelda
dc.contributor.authorSezgin, Serhat
dc.contributor.authorAladağ, Akın
dc.contributor.authorBülbül, Aziz
dc.date.accessioned2022-05-10T13:30:34Z
dc.date.available2022-05-10T13:30:34Z
dc.date.issued2022en_US
dc.identifier.citation1. Genç D, Bulut O, Günaydin B, Göksu M, Düzgün M, Dere Y, et al.. Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren’s syndrome murine model. PLOS ONE. PLOS ONE; 2022;17: e0266137. doi:10.1371/journal.pone.0266137en_US
dc.identifier.urihttps://doi.org/ 10.1371/journal.pone.0266137
dc.identifier.urihttps://hdl.handle.net/20.500.12809/9961
dc.description.abstractObjective: Dental mesenchymal stem cells (MSCs) are potential for use in tissue regeneration in inflammatory diseases due to their rapid proliferating, multilineage differentiation, and strong anti-inflammatory features. In the present study, immunoregulatory and glandular tissue regeneration effects of the dental follicle (DF)MSCs in Sjögren's Syndrome (SS) were investigated. Methods: Dental follicle (DF) tissues were obtained from healthy individuals during tooth extraction, tissues were digested enzymatically and DFMSCs were cultured until the third passage. DFMSCs were labeled with Quantum dot 655 for cell tracking analysis. The induction of the SS mouse model was performed by the injection of Ro60-273-289 peptide intraperitoneally. DFMSCs were injected intraperitoneally, or into submandibular, or lacrimal glands. Splenocytes were analyzed for intracellular cytokine (IFN-γ, IL-17, IL-10) secretion in T helper cells, lymphocyte proliferation, and B lymphocyte subsets. Histologic analysis was done for submandibular and lacrimal glands with hematoxylin-eosin staining for morphologic examination. Results: The systemic injection of DFMSCs significantly reduced intracellular IFN-γ and IL-17 secreting CD4+ T cells in splenocytes (p<0.05), and decreased inflammatory cell deposits and fibrosis in the glandular tissues. DFMSCs differentiated to glandular epithelial cells in submandibular and lacrimal injections with a significant reduction in lymphocytic foci. The results showed that few amounts of DFMSCs were deposited in glandular tissues when applied intraperitoneally, while high amounts of DFMSCs were located in glandular tissues and differentiated to glandular epithelial cells when applied locally in SS murine model. Conclusion: DFMSCs have the potential for the regulation of Th1, Th17, and Treg balance in SS, and ameliorate glandular dysfunction. DFMSCs can be a beneficial therapeutic application for SS.en_US
dc.item-language.isoengen_US
dc.publisherPlosen_US
dc.relation.isversionof10.1371/journal.pone.0266137en_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDental mesenchymalen_US
dc.titleDental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine modelen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Sağlık Bilimleri Fakültesi, Hemşirelik Bölümüen_US
dc.contributor.authorID0000-0003-0351-2805en_US
dc.contributor.institutionauthorGenç, Deniz
dc.contributor.institutionauthorBulut, Osman
dc.contributor.institutionauthorGünaydın, Burcu
dc.contributor.institutionauthorGöksu, Mizgin
dc.contributor.institutionauthorDüzgün, Mert
dc.contributor.institutionauthorDere, Yelda
dc.contributor.institutionauthorSezgin, Serhat
dc.contributor.institutionauthorAladağ, Akın
dc.contributor.institutionauthorBülbül, Aziz
dc.identifier.volume17en_US
dc.identifier.issue5en_US
dc.relation.journalPlos Oneen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster